Abstract:Introduction: Conventional pancreatic islet transplantation is a promising treatment for individuals with severe type 1 diabetes, however 70% of islets lose function limiting the boarder application of this treatment. Islets are highly vascularised and metabolically active cluster of cells for fine tuning of blood sugar levels to achieve euglycemia. Thus, revascularisation of transplanted islets is a key focus to encourage maximal function and islet survivability. Compared to conventional islet transplantation, 3D bioprinting introduces a method for the revascularisation of islets to support their function and survivability post-transplantation by mimicking the cellular architecture found in nature. Herein we reported a novel bioprinting platform that enables endothelial cells to self-assemble to form interconnected 3D vascular networks. Method: In this study, a colinear co-extrusion approach is utilised for the biofabrication of vascularised cell-laden constructs via a Janus nozzle which enables simultaneous side-by-side deposition of both cell-free structural ink and cell-laden bioink. The structural ink is comprised of 2% alginate-methacrylate (Alg-ma)/ 2%gelatin/7.5%gelatin methacryloyl (GelMA) and the cell-laden ink is comprised of 20mM CaCl2/2% gelatin/ 0.5mg/ml fibrinogen bioink which carries human umbilical vein endothelial cells (HUVECs). The 3D REDI a mechanical extruder 3D printer developed by TRICEP was used to fabricate a 10x10mm 4-layered scaffolds at a 300 mm/min speed, flowrate of 0.0005670 ml/min and printed at a 45° angle with a 560 µm Janus nozzle. Rheology was conducted on the structural bioink and mechanical testing was used on cell-free scaffolds to determine the physiochemical properties of the structural bioink and mechanical properties of the scaffold. To evaluate the cellular viability and function, observation of cellular behaviour, live/dead staining, and immunostaining for CD31 were conducted. Results: Rheological characterization demonstrated shear thinning behavior but also self-recovery behavior upon shear rate whilst mechanical testing supported structural stability of the construct. 3D bioprinting of HUVEC-laden constructs presented viable cells post-printing up to day 28 represented through live/dead staining but also cell morphological changes on day 1 and day 7.HUVECs were able to self-assemble into interconnected vessel like formations throughout the whole construct and expressed the CD31 marker.Conclusion: Colinear bioprinting precisely deposits filaments aiding structural integrity but also the formation of interconnected channels within the construct making this a highly attractive method for vascularisation. The ongoing in vivo study will provide further insight into how to optimise the colinear printing platform to improve vascularisation and islet survival rate following islet transplantation.

Stress-free Bioprinting of Human Primary and iPSC-derived Islets with Retained Functionality

Three-dimensional bioprinting of functional β-islet-like constructs

3 D manufactured islet micro-tissues for the treatment of type-1 diabetes

Development Of A Coaxial 3d Printing Platform For Biofabrication Of Implantable Islet-Containing Constructs

336.2: Development of a Model to Fabricate Vascularised 3D Bioprinted Constructs to Support Islet Transplantation for Type 1 Diabetes

A 3D bioprinted hybrid encapsulation system for delivery of human pluripotent stem cell-derived pancreatic islet-like aggregates

Engineering pore-enriched and pre-vascularized volumetric constructs for enhanced blood glucose regulation in type 1 diabetes therapy

A 3D-Printed Microdevice Encapsulates Vascularized Islets Composed of Ipsc-Derived Β-Like Cells and Microvascular Fragments for Type 1 Diabetes Treatment

Advances in Printing Biomaterials and Living Cells

3D printed VEGF-CPO biomaterial scaffold to promote subcutaneous vascularization and survival of transplanted islets for the treatment of diabetes

Hyaluronic acid methacrylate/pancreatic extracellular matrix as a potential 3D printing bioink for constructing islet organoids

Stem Cells as a Source of Pancreatic Cells for Production of 3D Bioprinted Bionic Pancreas in the Treatment of Type 1 Diabetes

3D Printing Mini-Capsule Device for Islet Delivery to Treat Type 1 Diabetes.

Viability and Functionality of Neonatal Porcine Islet-like Cell Clusters Bioprinted in Alginate-Based Bioinks

Three-in-one customized bioink for islet organoid: GelMA/ECM/PRP orchestrate pro-angiogenic and immunoregulatory function

Biomimetic Hydrogels Promote Pseudoislet Formation to Improve Glycemic Control in Diabetic Mice

The future treatment for type 1 diabetes: Pig islet- or stem cell-derived β cells?

3D Bioprinting of Multicellular Stem Cell‐Derived Constructs to Model Pancreatic Cell Differentiation

Islet cell spheroids produced by a thermally sensitive scaffold: a new diabetes treatment

Pancreatic islets seeded in a novel bioscaffold forms an organoid to rescue insulin production and reverse hyperglycemia in models of type 1 diabetes

Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation